BBH vs. UTHR
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and United Therapeutics Corporation (UTHR).
BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011.
Performance
BBH vs. UTHR - Performance Comparison
Loading graphics...
BBH vs. UTHR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.04% | 21.18% | -4.29% | 3.94% | -15.25% | 11.81% | 22.13% | 26.34% | -10.70% | 16.46% |
UTHR United Therapeutics Corporation | 17.04% | 38.09% | 60.46% | -20.93% | 28.70% | 42.35% | 72.33% | -19.12% | -26.39% | 3.15% |
Returns By Period
In the year-to-date period, BBH achieves a 0.04% return, which is significantly lower than UTHR's 17.04% return. Over the past 10 years, BBH has underperformed UTHR with an annualized return of 6.42%, while UTHR has yielded a comparatively higher 17.58% annualized return.
BBH
- 1D
- 0.70%
- 1M
- -3.58%
- YTD
- 0.04%
- 6M
- 10.55%
- 1Y
- 23.57%
- 3Y*
- 5.92%
- 5Y*
- 1.84%
- 10Y*
- 6.42%
UTHR
- 1D
- -3.83%
- 1M
- 10.99%
- YTD
- 17.04%
- 6M
- 30.15%
- 1Y
- 85.83%
- 3Y*
- 36.55%
- 5Y*
- 24.28%
- 10Y*
- 17.58%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBH vs. UTHR — Risk / Return Rank
BBH
UTHR
BBH vs. UTHR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and United Therapeutics Corporation (UTHR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBH | UTHR | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.05 | 1.71 | -0.66 |
Sortino ratioReturn per unit of downside risk | 1.53 | 3.11 | -1.58 |
Omega ratioGain probability vs. loss probability | 1.20 | 1.43 | -0.23 |
Calmar ratioReturn relative to maximum drawdown | 2.00 | 5.20 | -3.20 |
Martin ratioReturn relative to average drawdown | 5.56 | 13.21 | -7.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BBH | UTHR | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.05 | 1.71 | -0.66 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.09 | 0.69 | -0.60 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.29 | 0.50 | -0.21 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.27 | 0.39 | -0.12 |
Correlation
The correlation between BBH and UTHR is 0.47, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
BBH vs. UTHR - Dividend Comparison
BBH's dividend yield for the trailing twelve months is around 0.51%, while UTHR has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.51% | 0.51% | 0.80% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% |
UTHR United Therapeutics Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BBH vs. UTHR - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.70%, smaller than the maximum UTHR drawdown of -93.18%. Use the drawdown chart below to compare losses from any high point for BBH and UTHR.
Loading graphics...
Drawdown Indicators
| BBH | UTHR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -72.70% | -93.18% | +20.48% |
Max Drawdown (1Y)Largest decline over 1 year | -10.47% | -16.35% | +5.88% |
Max Drawdown (5Y)Largest decline over 5 years | -39.86% | -33.00% | -6.86% |
Max Drawdown (10Y)Largest decline over 10 years | -39.86% | -55.56% | +15.70% |
Current DrawdownCurrent decline from peak | -12.15% | -3.83% | -8.32% |
Average DrawdownAverage peak-to-trough decline | -26.05% | -35.52% | +9.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.76% | 6.43% | -2.67% |
Volatility
BBH vs. UTHR - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 7.01%, while United Therapeutics Corporation (UTHR) has a volatility of 17.27%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than UTHR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BBH | UTHR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.01% | 17.27% | -10.26% |
Volatility (6M)Calculated over the trailing 6-month period | 13.69% | 27.12% | -13.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.72% | 50.58% | -27.86% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.47% | 35.31% | -13.84% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.27% | 35.33% | -13.06% |